Objective
This project's objective is to develop a wound dressing product that will address the unmet needs of patients with chronic wounds. The prevalence of chronic wounds is increasing and results in a growing utilization of healthcare and financial resources. The available wound care options can manipulate one or multiple aspects of the wound environment, but cannot form antibacterial barriers and facilitate healing to a satisfactory level at the same time.
Colzyx aims to address this challenge by developing an innovative wound dressing product that will make use of the newlydiscovered healing and antimicrobial properties of human collagen VI. It is first-in-class product which uses highly functional molecules from the human innate immune system in wound management. This novel technology combines these potent molecules with a biomembrane – established in wound management market. Together, they effectively enhance wound closure and fight bacterial infection simultaneously.
This approach offers significant benefits to patients by reducing pain and discomfort, and accelerating recovery. It will also shorten hospitalisation time and decrease labour for healthcare professionals and the financial burden. Comparing to available wound dressings, Colzyx’s product is unique and will address a new market category of interactive biomembranes.
The ultimate success will depend on the quality of confirmatory data and agreement with development partner to share the challenges of subsequent research and market introduction. Colzyx plans to take the product through the CE-mark registration study and reach the market through an agreement with a strong defined licence partner.
The problem of pathogenic resistance to drugs is growing and highlighted by the national and international health organisations. This adds to the significance of the challenge posed by chronic wounds and ensures Colzyx in the endeavour of developing and bringing to the market its novel wound dressing.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
223 81 Lund
Sweden
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.